Who is sponsoring ROSEZE?

ROSEZE is sponsored by Collegium Medicum w Bydgoszczy.

What condition does ROSEZE study?

ROSEZE studies Hypercholesterolemia.

What drugs are being tested in ROSEZE?

Interventions: Rosuvastatin and Ezetimibe morning or evening administration.

Last reviewed 2021-01-29 · How we verify

The Impact of the Time of Drug Administration on the Effectiveness of Combined Treatment of Hypercholesterolemia With ROSuvastatin and EZEtimibe (ROSEZE) - A Single-center, Crossover, Open-label Study

NCT02772640 Phase 4 COMPLETED

The aim of the study is to demonstrate, whether the time of day of administration of the study drug (containing rosuvastatin and ezetimibe) has an impact on the effectiveness of lipid-lowering therapy.

Details

Lead sponsor	Collegium Medicum w Bydgoszczy
Phase	Phase 4
Status	COMPLETED
Enrolment	83
Start date	2016-03
Completion	2020-05

Conditions

Hypercholesterolemia

Interventions

Rosuvastatin and Ezetimibe morning or evening administration

Primary outcomes

Change in total cholesterol and LDL-Cholesterol — 6 and 12 weeks
Change in total cholesterol and LDL-Cholesterol at 6 and 12 weeks of study drug treatment (combination of ezetimibe and rosuvastatin), depending on the time of day of study drug administration

Countries

Poland